CHICAGO, Nov 20 (Reuters) - Breakthrough Alzheimer’s treatments that remove toxic proteins from the brain have revived interest in vaccines to treat the memory-robbing disease, potentially ...
Citation: New Alzheimer's drug shines light on need for assessments to head off 'a tsunami of cognitive afflictions' (2023, November 20) retrieved 5 December 2023 from https://medicalxpress.com ...
Anavex's Alzheimer's drug Blarcamesine demonstrates strong statistical significance in improving cognition among dementia patients as measured by one co-primary endpoint and one secondary endpoint.
The Alzheimer’s epidemic continues to cast a shadow over the lives of millions of people. But researchers believe they are closer than ever before to finding effective treatments.
ABOUT A STUDY INVOLVING AN FDA APPROVED DRUG FOR ALZHEIMER’S. THE STUDY IS CALLED AHEAD AND BOTH DUKE AND WAKE FOREST UNIVERSITIES ARE CONDUCTING CLINICAL TRIALS THAT YOU MAY BE ABLE TO JOIN.
Move over, Ozempic — there’s a new drug in town. Eli Lilly’s Zepbound, with the active ingredient tirzepatide, has been approved by the Food and Drug Administration for use by obese or ...
According to the Centers for Disease Control and Prevention, Alzheimer's is the seventh leading cause of death in Ohio, which recorded a 34.2% Alzheimer's mortality rate in 2021 with 4,947 deaths ...
This image provided by Eli Lilly on Wednesday, Nov. 8, 2023 shows packaging for their new drug Zepbound. The new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss ...
Nov. 20—(StatePoint) 2023 was a landmark year for Alzheimer's disease research, including advancements in treatment, risk factors and diagnosis. Here are five significant discoveries made this year: ...
Researchers Return to Alzheimer's Vaccines, Buoyed by Recent Drug Success By Julie Steenhuysen CHICAGO (Reuters) - Breakthrough Alzheimer’s treatments that remove toxic proteins from the brain ...
CHICAGO, Nov 20 (Reuters) - Breakthrough Alzheimer’s treatments that remove toxic proteins from the brain have revived interest in vaccines to treat the memory-robbing disease, potentially ...
